Study of early aging after chemotherapy in young testicular cancer patients
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at how chemotherapy may affect “early aging” in people who had metastatic testicular cancer before age 50. It includes people who are starting cisplatin-based chemotherapy and a comparison group with earlier-stage disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had testicular cancer that was metastatic (stage II or higher)
- Your cancer treatment included cisplatin-based chemotherapy as first treatment
- You were younger than 50 when the chemotherapy started (or when metastatic disease was diagnosed)
- If you join the comparison group, you had stage I testicular cancer and were younger than 50 at diagnosis
- You can understand the study and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how “early aging” changes show up during treatment in young adults with cancer. It may help doctors better understand health effects during curative therapy and improve care for people your age.
This study looks at how people should be followed after treatment for testicular cancer (surgery and, for some, chemotherapy). It may help improve follow-up plans while keeping an eye out for cancer coming back.
This study asks adults with newly diagnosed testicular cancer about their experiences before any cancer treatment starts. It may help researchers understand what patients need and how trial care affects real life.
This study looks at how thinking and memory may change in children and young adults after a new cancer diagnosis, especially around chemotherapy. It may help doctors better understand and track brain-related side effects early.
This trial looks at how certain immune cells (T cells) change with age and how that might affect how well chemotherapy works in young women with triple-negative breast cancer (TNBC). It aims to learn more about why some patients respond better to treatment.
This study looks at how chemotherapy and immunotherapy affect the body in older adults with colorectal cancer, especially early side effects. It may help researchers understand why some people lose strength and how to better predict and manage treatment toxicity.
Hear when a new Testicular Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.